• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Aemetis Announces Updated Five Year Plan Projecting Growth to $1.95 Billion of Revenue and $645 Million of Adjusted EBITDA in 2028

    2/20/24 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials
    Get the next $AMTX alert in real time by email

    CUPERTINO, CA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, today announced an updated Aemetis Five Year Plan (the "2024 Plan") that projects the company will generate $1.95 billion in revenues and $645 million of adjusted EBITDA in year 2028. 

    The 2024 Plan states revenues are expected to grow at a compound annual growth rate of 38%, and adjusted EBITDA is expected to grow at a projected compound annual growth rate of 83% for the years 2024 to 2028.

    A presentation summarizing the updated Five Year Plan is available for review on the Aemetis website at www.aemetis.com/Five-Year-Plan.

    In the Aemetis 2024 Five Year Plan, the Company's revenue and adjusted EBITDA growth is expected from 75 dairies producing RNG by 2028; from a 90 million gallon per year sustainable aviation fuel and renewable diesel (SAF/RD) plant in Riverbank, California; from a CO2 Carbon Sequestration and Underground Storage (CCUS) well located near the Riverbank and Keyes biofuels plant sites in California; from the completion of solar, mechanical vapor recompression and other energy efficiency, carbon emission reduction, and electrification projects at our Keyes biofuels plant; and from the continued expansion of biodiesel and tallow refining production at the Aemetis plant in India. The presentation also describes the tax credits expected to be received by Aemetis from the Inflation Reduction Act (IRA) for its renewable fuel and sequestration projects.

    "Through the expansion of our RNG, biodiesel, SAF/RD, CCUS, and ethanol businesses, Aemetis is poised to rapidly grow revenue to almost $2 billion by the end of 2028," said Eric McAfee, Chairman and CEO of Aemetis.  "Additionally, Aemetis closed $50 million of new USDA funding and received $55 million from the sale of IRA tax credits in the past year.  With strong financing support from the USDA for renewable fuels projects, the passage of the $380 billion Inflation Reduction Act to provide funding to renewable energy projects, and EPA approval allowing 15% ethanol blends in 49 states which expands the ethanol market by almost 50%, the regulatory and financial climate for renewable energy projects continues to support our overall growth plan," added McAfee.

    Significant milestones were achieved in the past year under the previous 2023 Five Year Plan, including the transition to receiving revenue and positive operational cash flow from the biogas-to-RNG upgrading facility and dairy digesters; receiving the Use Permit and CEQA approval for the SAF/RD plant at the Riverbank site; receiving the first private carbon sequestration characterization well drilling permit issued by the State of California; completing construction and commissioning of the 1.9 megawatt solar microgrid with battery backup; installing an Allen Bradley distributed control system with AI capabilities to optimize energy use and other operational performance of the Keyes ethanol plant; completing design engineering and are now procuring equipment for the Mechanical Vapor Recompression (MVR) unit at the Keyes plant to utilize low carbon intensity electricity instead of fossil natural gas; completing deliveries of biodiesel to the Oil Marketing Companies in India under the first $40 million of contracts; and receiving awards for an additional $150 million of allocations from the three India government Oil Marketing Companies to be fulfilled using a Cost-Plus pricing formula.

    Due to uncertainties regarding timing, the 2024 Plan does not include several other growth initiatives that are actively under development at Aemetis, including revenues and EBITDA from the planned operation of the 50 million gallon per year capacity, debt-free, India refined tallow plant.  The export of tallow from India to North America customers at approximately $4 to $5 per gallon for 50 million gallons per year, increasing revenues by up to $250 million per year, is excluded.  The 2024 Plan projections include using the refined tallow from India as a feedstock supply source for the operations of the SAF/RD plant under development in California to improve profit margins.

    In addition to the $55 million received in Q4 2024 from the sale of transferable tax credits, the Inflation Reduction Act is expected to provide transferable investment and production tax credits to Aemetis related to our U.S. renewable fuels and CO2 sequestration projects, which are included in the 2024 Plan.

    The Five Year Plan for Aemetis Dairy RNG operations projects revenues will grow from $18 million in 2024 to $190 million in 2028, while Dairy RNG project EBITDA is expected to expand from $7 million in 2024 to $123 million in 2028. The RNG plan accounts for the delays in receiving LCFS revenue that are caused by the current regulatory process to obtain LCFS pathway approvals for each dairy digester that may be shortened if pending regulatory changes are adopted by the California Air Resources Board.

    The Five Year Plan projects that the Aemetis Sustainable Aviation Fuel and Renewable Diesel plant will provide revenue of $672 million with adjusted EBITDA of $195 million in year 2027 from the 90 million gallon plant that received the Use Permit and CEQA approval in September 2023 to be built at the 125-acre Riverbank Industrial Complex which has 100% renewable hydroelectricity; a rail line and storage for 120 railcars; 710,000 square feet of buildings; and 50 acres of developable industrial land.

    In connection with the carbon reduction upgrades at the Keyes plant, expansions of the India biodiesel plant, and expanded market opportunities resulting from changes to governmental policies, the Five Year Plan projects that the Company will generate annual revenue from ethanol and biodiesel of approximately $826 million in 2028, up from $368 million of expected revenue in 2024.

    About Aemetis

    Headquartered in Cupertino, California, Aemetis is a renewable natural gas, renewable fuel and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace petroleum-based products and reduce greenhouse gas emissions. Founded in 2006, Aemetis is operating and actively expanding a California biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas. Aemetis owns and operates a 65 million gallon per year ethanol production facility in California's Central Valley near Modesto that supplies about 80 dairies with animal feed. Aemetis owns and operates a 60 million gallon per year production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis is developing the sustainable aviation fuel (SAF) and renewable diesel fuel biorefinery in California to utilize renewable hydrogen, hydroelectric power, and renewable oils to produce low carbon intensity renewable jet and diesel fuel. For additional information about Aemetis, please visit www.aemetis.com.

    Safe Harbor Statement

    This news release contains forward-looking statements, including statements regarding assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements include, without limitation, projections of financial results in 2024 and future years, statements relating to the development, construction, and operation of the Aemetis Biogas RNG operations, the SAF and renewable diesel plant, and the carbon capture and sequestration wells, modifications to the Keyes plant, future changes to our India operations., and our ability to promote, develop and deploy technologies to produce renewable fuels and biochemicals. Words or phrases such as "anticipates," "may," "will," "should," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "showing signs," "targets," "view," "will likely result," "will continue" or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol, biodiesel and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2022, and in our subsequent filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.

    External Investor Relations

    Contact:

    Kirin Smith

    PCG Advisory Group

    (646) 863-6519

    [email protected]

    Company Investor Relations/

    Media Contact:

    Todd Waltz

     (408) 213-0940

    [email protected]



    Primary Logo

    Get the next $AMTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMTX

    DatePrice TargetRatingAnalyst
    8/16/2023$2.50 → $10.50Neutral → Buy
    UBS
    2/28/2023$3.00Underweight
    Piper Sandler
    12/14/2022$4.25Neutral
    UBS
    8/9/2022$12.00Buy → Hold
    Truist
    11/22/2021$31.00 → $35.00Outperform
    Credit Suisse
    8/23/2021$40.00 → $31.00Outperform
    Credit Suisse
    7/15/2021$25.00Outperform
    Evercore ISI Group
    More analyst ratings

    $AMTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aemetis Reports Fourth Quarter and Full Year 2025 Results as Dairy RNG Platform Scales

    Dairy RNG production increased 61% year over year in Q4 2025; ethanol plant efficiency upgrade expected to increase plant cash flow from operations by approximately $32 million annually Aemetis Biogas segment net income increased to $12.2 million in Q4 2025Aemetis Biogas segment increased annual revenues and production tax credits by 53%Dairy RNG production increased 61% year over year in Q4 2025Aemetis Biogas achieved annual segment net income of $6.9 millionCapital investments increased 28% over the prior year to $26.0 million, supporting dairy RNG expansion and ethanol plant energy efficiency upgradesDairy digester projects generated cash proceeds of $18 million during 2025 from the sale

    3/12/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis to Review Fourth Quarter and Year End 2025 Financial Results on March 12, 2026

    CUPERTINO, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX) announced that the company will host a conference call to review the release of its fourth quarter and year end 2025 earnings report: Date: Thursday, March 12, 2026 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 452750 Live Participant Dial In (International): +1-973-528-0011 entry code 452750 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/53629 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call. The webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Cal

    3/6/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis India Subsidiary Begins Biodiesel Deliveries Under $24 Million Allocation from OMCs

    CUPERTINO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX), a diversified renewable natural gas and biofuels company, announced that its Universal Biofuels subsidiary in India secured allocations of approximately $24 million for the supply of more than 27 million liters of biodiesel to India's three government-owned Oil Marketing Companies (OMCs) for the period ending March 2026. Additional OMC fuel supply orders are expected throughout the year to support the India government's goal of increasing from a 1% biodiesel blend to a targeted 5%, as stated in the current India National Policy on Biofuels. "Universal Biofuels and other biodiesel producers look forward to c

    2/3/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aemetis upgraded by UBS with a new price target

    UBS upgraded Aemetis from Neutral to Buy and set a new price target of $10.50 from $2.50 previously

    8/16/23 8:55:59 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Piper Sandler initiated coverage on Aemetis with a new price target

    Piper Sandler initiated coverage of Aemetis with a rating of Underweight and set a new price target of $3.00

    2/28/23 6:17:45 AM ET
    $AMTX
    Major Chemicals
    Industrials

    UBS initiated coverage on Aemetis with a new price target

    UBS initiated coverage of Aemetis with a rating of Neutral and set a new price target of $4.25

    12/14/22 7:31:59 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    SEC Filings

    View All

    Aemetis Inc. (DE) filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - AEMETIS, INC (0000738214) (Filer)

    3/16/26 4:18:27 PM ET
    $AMTX
    Major Chemicals
    Industrials

    SEC Form S-8 filed by Aemetis Inc. (DE)

    S-8 - AEMETIS, INC (0000738214) (Filer)

    3/16/26 8:12:32 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis Inc. (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AEMETIS, INC (0000738214) (Filer)

    3/12/26 8:30:09 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Mcafee Eric A

    4 - AEMETIS, INC (0000738214) (Issuer)

    3/23/26 8:16:21 PM ET
    $AMTX
    Major Chemicals
    Industrials

    Director Simon Timothy Alan was granted 12,000 shares, increasing direct ownership by 30% to 52,632 units (SEC Form 4)

    4 - AEMETIS, INC (0000738214) (Issuer)

    1/28/26 8:08:09 PM ET
    $AMTX
    Major Chemicals
    Industrials

    Director Block John R was granted 12,000 shares, increasing direct ownership by 35% to 46,330 units (SEC Form 4)

    4 - AEMETIS, INC (0000738214) (Issuer)

    1/28/26 8:07:34 PM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Financials

    Live finance-specific insights

    View All

    Aemetis Reports Fourth Quarter and Full Year 2025 Results as Dairy RNG Platform Scales

    Dairy RNG production increased 61% year over year in Q4 2025; ethanol plant efficiency upgrade expected to increase plant cash flow from operations by approximately $32 million annually Aemetis Biogas segment net income increased to $12.2 million in Q4 2025Aemetis Biogas segment increased annual revenues and production tax credits by 53%Dairy RNG production increased 61% year over year in Q4 2025Aemetis Biogas achieved annual segment net income of $6.9 millionCapital investments increased 28% over the prior year to $26.0 million, supporting dairy RNG expansion and ethanol plant energy efficiency upgradesDairy digester projects generated cash proceeds of $18 million during 2025 from the sale

    3/12/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis to Review Fourth Quarter and Year End 2025 Financial Results on March 12, 2026

    CUPERTINO, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX) announced that the company will host a conference call to review the release of its fourth quarter and year end 2025 earnings report: Date: Thursday, March 12, 2026 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 452750 Live Participant Dial In (International): +1-973-528-0011 entry code 452750 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/53629 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call. The webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Cal

    3/6/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis to Review Third Quarter 2025 Financial Results on November 6, 2025

    CUPERTINO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX) announced that the company will host a conference call to review the release of its third quarter 2025 earnings report: Date: Thursday, November 6, 2025 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 188767  Live Participant Dial In (International): +1-973-528-0011 entry code 188767 Webcast URL: https://www.webcaster5.com/Webcast/Page/2211/53150 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call. The webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Calls, along w

    10/31/25 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Aemetis Inc. (DE) (Amendment)

    SC 13G/A - AEMETIS, INC (0000738214) (Subject)

    2/14/24 4:19:02 PM ET
    $AMTX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Aemetis Inc. (DE) (Amendment)

    SC 13G/A - AEMETIS, INC (0000738214) (Subject)

    2/14/24 2:54:17 PM ET
    $AMTX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Aemetis Inc. (DE) (Amendment)

    SC 13G/A - AEMETIS, INC (0000738214) (Subject)

    2/13/24 6:50:28 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Leadership Updates

    Live Leadership Updates

    View All

    Aemetis Appoints J. Michael Rockett as Executive Vice President, General Counsel and Corporate Secretary

    CUPERTINO, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, has appointed J. Michael Rockett as Executive Vice President, General Counsel and Corporate Secretary, effective immediately. Mr. Rockett brings over 28 years of relevant experience to the company. Prior to joining Aemetis, he was Vice President, General Counsel, and Corporate Secretary of InEnTec Inc., a developer of technology and facilities to convert waste into renewable fuels and chemical products. Mr. Rockett was formerly an attorney at the law firm of Pillsbury Winthrop Shaw Pittman L

    8/28/23 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis Appoints Former California Public Utilities Commissioner Timothy Simon to the Aemetis Board of Directors

    CUPERTINO, CA, Oct. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas (RNG) and renewable fuels company focused on negative carbon intensity products, today announced the appointment of Timothy Alan Simon, Esq., former Commissioner of the California Public Utilities Commission (CPUC), to the Company's Board of Directors, effective October 14.  Mr. Simon was appointed to the CPUC by Governor Arnold Schwarzenegger in February 2007, ending his term in December 2012. During his time as a CPUC commissioner, Mr. Simon served as Chair of the National Association of Regulatory Utility Commissioners ("NARUC") Natural Gas Committee; Chair of the

    10/18/21 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Indonesia Energy Corporation Announces Appointment of Michael L. Peterson to Board of Directors

    Experienced energy industry and finance executive to serve as Chairman of IEC's Audit Committee JAKARTA, INDONESIA AND DANVILLE, CA / ACCESSWIRE / January 25, 2021 / Indonesia Energy Corporation (NYSE American:INDO) ("IEC"), an oil and gas exploration and production company focused on Indonesia, today announced that the company's Board of Directors has appointed Michael L. Peterson to the Board. Mr. Peterson will serve as an independent Board member and will also serve as the Chairman of the Audit Committee of the Board of Directors. Mr. Peterson has over 30 years of experience in executive management positions in all aspects of the energy industry and finance industries, having served as

    1/25/21 9:00:00 AM ET
    $PED
    $MEDS
    $INDO
    Oil & Gas Production
    Energy
    Other Pharmaceuticals
    Health Care